Back

Earlier rilonacept use in recurrent pericarditis reduces subsequent recurrence burden and treatment escalation: outcomes from the RESONANCE patient registry

29 August 2026 (16:15 - 16:40)
Organised by: Logo
Congress Presentation Part of: Tumours of the heart: clinical insights and emerging evidence Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Paul Cremer

Cleveland Clinic Foundation, Cleveland (United States of America)

3 More presentations in this session

Presentation thumbnail
Diagnostic accuracy of an integrated multimodality imaging approach in patients with cardiac masses
Doctor M. Moretti (Bologna, IT)
Abstract Slides
Presentation thumbnail
From constriction to recovery: prognosis after pericardiectomy in constrictive pericarditis
Doctor J. Costabel (Buenos Aires, AR)
Abstract Slides
Presentation thumbnail
Sex-specific prognostic significance of right-sided cardiopulmonary remodelling among patients undergoing intervention for primary mitral regurgitation
Miss H. Yasir (Greater London, GB)
Abstract Slides

Access the full session

Session thumbnail
Tumours of the heart: clinical insights and emerging evidence

The Event

Event poster

ESC Congress 2026

29 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Increased adoption of IL-1 pathway inhibition and the steroid-sparing paradigm shift: temporal trends in recurrent pericarditis treatment from the RESONANCE patient registry
31 August 2024
thumbnail
Congress Presentation
Multidisciplinary approach to managing recurrent pericardial effusion in cancer patients: insights from a 5-year single-center experience
20 June 2025
thumbnail
Congress Presentation
Effect of alirocumab on recurrent cardiovascular events after acute coronary syndrome, according to the intensity of background statin treatment
2 September 2019
thumbnail
Congress Presentation
Genetic analysis of NLRP3 in recurrent pericarditis
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources